COVID-19 Update:Learn where you can get your child vaccinated, as well as other important facts about COVID-19.
Leader in Care
Throughout the Washington, D.C, region, the nation and the world, Children’s National Hospital is recognized for our expertise and innovation in pediatric care and as an advocate for all children.Read more
A new study from Children’s National Hospital in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) will examine the long-term effects of COVID-19 and multisystem inflammatory syndrome in children (MIS-C) after patients have recovered from a COVID-19 infection.
Children’s National Hospital announces a $12.8 million award from the National Institutes of Health’s National Human Genome Research Institute (NHGRI) to establish the Pediatric Mendelian Genomics Research Center (PMGRC) as part of a new Mendelian Genomics Research Consortium. Researchers at Children’s National and Invitae — a leading medical genetics company — will identify novel causes of rare inherited diseases, investigate the mechanisms of undiagnosed conditions, enhance data sharing, and generally interrogate Mendelian phenotypes, which are conditions that run in families.
Children’s National Hospital announces that it has entered into a licensing agreement with MGeneRx Inc. for its patented pediatric medical device technology using objective digital biometric analysis software for the early and non-invasive screening of dysmorphic genetic diseases. The technology was developed by Children’s National to provide a more advanced diagnostic tool for regions of the world with limited access to geneticists or genetic testing. MGeneRx is a spinoff from BreakThrough BioAssets LLC, a life sciences technology operating company focused on accelerating and commercializing new innovations, such as this technology, with an emphasis on positive social impact.
Children’s National Hospital announced a second year of success for its Conway Nursing Pathway Program, during a time of heightened stress for health care providers due to the COVID-19 pandemic.The program offers scholarship, mentorship and work study for nurses at all stages of their careers, aiming to deepen career satisfaction and reduce the financial burden of higher education. The result is better care for children from more passionate, experienced nurses.
Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children’s National Hospital in Washington, D.C.
Reinforcing its commitment to expanding innovation in pediatric care, Children’s National Hospital is joining with the Center for Advancing Innovation (CAI) , and collaborators Resonance Philanthropies and Digital Infuzion, to launch the 2021-2022 Innovate Children’s Health Challenge to encourage the commercialization of technologies that improve children’s health care. This year’s event, Innovate Children’s Health II, focuses on technologies that address pandemic resiliency and prevention in the pediatric population and seeks to advance diagnostics, therapeutics and digital health tools that address pediatric mental health.
For the fifth straight year, U.S. News & World Report ranked Children’s National a top 10 children’s hospital for its Best Children’s Hospitals annual rankings for 2021-22, with a #1 ranking in newborn care. Learn more about our specialty care rankings.
The Bear Institute is announcing the first annual Bear Institute PACK (Pediatric Accelerator Challenge for Kids), a start-up competition to address the gap in digital health innovation funding dedicated to children.
Children’s National Hospital is pleased to announce it has selected Muller Fabbri, M.D., Ph.D., as associate director for the Center for Cancer and Immunology Research at the Children’s National Research Institute. In this role, he will build and lead the Cancer Biology Program while developing and conducting basic and translational research. Dr. Fabbri will also develop multidisciplinary research projects with various clinical divisions, including oncology, blood and marrow transplantation, pathology and hematology.
The new class of residents arriving at Children’s National Hospital is the hospital’s most diverse class ever.